Sofosbuvir as a potential option for the treatment of COVID-19

por Nourian, Anahid, Khalili, Hossein
Publicado 2020

Efficacy and safety of sofosbuvir/ledipasvir in treatment of patients with COVID-19; A randomized clinical trial

por Nourian, Anahid, Khalili, Hossein, Ahmadinejad, Zahra, Emadi Kouchak, Hamid, Jafari, Sirous, Dehghan Manshadi, Sayed Ali, Rasolinejad, Mehrnaz, Kebriaeezadeh, Abbas
Publicado 2020

Interferon β-1b in treatment of severe COVID-19: A randomized clinical trial

por Rahmani, Hamid, Davoudi-Monfared, Effat, Nourian, Anahid, Khalili, Hossein, Hajizadeh, Nooshin, Jalalabadi, Narjes Zarei, Fazeli, Mohammad Reza, Ghazaeian, Monireh, Yekaninejad, Mir Saeed
Publicado 2020

Comparing efficacy and safety of different doses of dexamethasone in the treatment of COVID-19: a three-arm randomized clinical trial

por Toroghi, Negar, Abbasian, Ladan, Nourian, Anahid, Davoudi-Monfared, Effat, Khalili, Hossein, Hasannezhad, Malihe, Ghiasvand, Fereshteh, Jafari, Sirous, Emadi-Kouchak, Hamid, Yekaninejad, Mir Saeed
Publicado 2021

Comparing outcomes of hospitalized patients with moderate and severe COVID-19 following treatment with hydroxychloroquine plus atazanavir/ritonavir

por Rahmani, Hamid, Davoudi-Monfared, Effat, Nourian, Anahid, Nabiee, Morteza, Sadeghi, Setayesh, Khalili, Hossein, Abbasian, Ladan, Ghiasvand, Fereshteh, Seifi, Arash, Hasannezhad, Malihe, Ghaderkhani, Sara, Mohammadi, Mostafa, Yekaninejad, Mir Saeed
Publicado 2020